577 related articles for article (PubMed ID: 11014332)
1. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies.
Opie LH; Yusuf S; Kübler W
Prog Cardiovasc Dis; 2000; 43(2):171-96. PubMed ID: 11014332
[TBL] [Abstract][Full Text] [Related]
2. [Differential therapy with calcium antagonists].
Scholze JE
Herz; 2003 Dec; 28(8):754-63. PubMed ID: 14689111
[TBL] [Abstract][Full Text] [Related]
3. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
4. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients.
Costanzo P; Perrone-Filardi P; Petretta M; Marciano C; Vassallo E; Gargiulo P; Paolillo S; Petretta A; Chiariello M
J Hypertens; 2009 Jun; 27(6):1136-51. PubMed ID: 19451836
[TBL] [Abstract][Full Text] [Related]
5. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy.
Deedwania PC
Cardiol Clin; 2005 May; 23(2):139-52. PubMed ID: 15694743
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockers in treatment of hypertension.
Muntwyler J; Follath F
Prog Cardiovasc Dis; 2001; 44(3):207-16. PubMed ID: 11727278
[TBL] [Abstract][Full Text] [Related]
7. Calcium channel blockers: an evidence-based review.
Waters D
Can J Cardiol; 1997 Aug; 13(8):757-66. PubMed ID: 9284842
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
9. Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis.
Bangalore S; Parkar S; Messerli FH
Am J Med; 2009 Apr; 122(4):356-65. PubMed ID: 19332231
[TBL] [Abstract][Full Text] [Related]
10. Use of calcium channel blockers in hypertension.
Conlin PR; Williams GH
Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
[TBL] [Abstract][Full Text] [Related]
11. Use of calcium channel blockers in cardiovascular risk reduction: issues in Latin America.
Alcocer L; Bendersky M; Acosta J; Urina-Triana M
Am J Cardiovasc Drugs; 2010; 10(3):143-54. PubMed ID: 20524716
[TBL] [Abstract][Full Text] [Related]
12. [Views on the use of calcium channel blockers in the treatment of heart ischemia and hypertension].
Halawa B
Pol Merkur Lekarski; 1998 Sep; 5(27):107-10. PubMed ID: 10101470
[TBL] [Abstract][Full Text] [Related]
13. Hypertension, possible vascular protection and lercanidipine.
Ram CV
Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):783-8. PubMed ID: 17173495
[TBL] [Abstract][Full Text] [Related]
14. Should calcium antagonists be first line drugs in hypertension?
Furberg CD; Psaty BM
Herz; 1995 Dec; 20(6):365-9. PubMed ID: 8582696
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G
Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534
[TBL] [Abstract][Full Text] [Related]
16. Calcium channel blockers for hypertension: dissecting the evidence for adverse effects.
Opie LH
Am J Hypertens; 1997 May; 10(5 Pt 1):565-77. PubMed ID: 9160770
[TBL] [Abstract][Full Text] [Related]
17. Revival of nifedipine, a dihydropyridine-based calcium blocker.
Yamagishi S; Nakamura K
Med Hypotheses; 2007; 68(3):565-7. PubMed ID: 17011717
[TBL] [Abstract][Full Text] [Related]
18. The safety of calcium-channel blockers.
Massie BM
Clin Cardiol; 1998 Dec; 21(12 Suppl 2):II12-7. PubMed ID: 9853194
[TBL] [Abstract][Full Text] [Related]
19. Calcium channel blockers and coronary heart disease.
Inzitari M; Di Bari M; Marchionni N
Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):6-15. PubMed ID: 16640169
[TBL] [Abstract][Full Text] [Related]
20. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
Kuti EL; Baker WL; White CM
Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
